IL97714A - Inclusion complexes of N-ethoxycarbonyl-3-morphonilo-Sidnonamine or salts formed with the history of cyclodextrin, their preparation and pharmaceutical preparations - Google Patents

Inclusion complexes of N-ethoxycarbonyl-3-morphonilo-Sidnonamine or salts formed with the history of cyclodextrin, their preparation and pharmaceutical preparations

Info

Publication number
IL97714A
IL97714A IL9771491A IL9771491A IL97714A IL 97714 A IL97714 A IL 97714A IL 9771491 A IL9771491 A IL 9771491A IL 9771491 A IL9771491 A IL 9771491A IL 97714 A IL97714 A IL 97714A
Authority
IL
Israel
Prior art keywords
cyclodextrin
ethoxycarbonyl
morpholino
molsidomin
sydnonimine
Prior art date
Application number
IL9771491A
Other languages
English (en)
Hebrew (he)
Other versions
IL97714A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU904013A external-priority patent/HUT59399A/hu
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL97714A0 publication Critical patent/IL97714A0/xx
Publication of IL97714A publication Critical patent/IL97714A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9771491A 1990-03-28 1991-03-28 Inclusion complexes of N-ethoxycarbonyl-3-morphonilo-Sidnonamine or salts formed with the history of cyclodextrin, their preparation and pharmaceutical preparations IL97714A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU901868A HU210921B (en) 1990-03-28 1990-03-28 Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU904013A HUT59399A (en) 1989-11-30 1990-06-27 Process for producing substituted 3-aminosydnone imine derivatives and pharmaceutical compositions comprising same

Publications (2)

Publication Number Publication Date
IL97714A0 IL97714A0 (en) 1992-06-21
IL97714A true IL97714A (en) 1995-03-30

Family

ID=10956592

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9771491A IL97714A (en) 1990-03-28 1991-03-28 Inclusion complexes of N-ethoxycarbonyl-3-morphonilo-Sidnonamine or salts formed with the history of cyclodextrin, their preparation and pharmaceutical preparations

Country Status (34)

Country Link
US (1) US5403840A (bg)
EP (1) EP0477315B1 (bg)
JP (1) JP2582497B2 (bg)
KR (1) KR950004705B1 (bg)
CN (1) CN1051080C (bg)
AT (1) ATE138656T1 (bg)
AU (1) AU638824B2 (bg)
BG (1) BG61689B1 (bg)
BR (1) BR9105136A (bg)
CA (1) CA2054188C (bg)
CZ (1) CZ287353B6 (bg)
DE (1) DE69119853T2 (bg)
DK (1) DK0477315T3 (bg)
ES (1) ES2090320T3 (bg)
FI (1) FI102460B1 (bg)
GE (1) GEP19991832B (bg)
GR (1) GR3020684T3 (bg)
HR (1) HRP920561B1 (bg)
HU (1) HU210921B (bg)
IL (1) IL97714A (bg)
LT (1) LT3394B (bg)
LV (1) LV10245B (bg)
MC (1) MC2185A1 (bg)
MD (1) MD679G2 (bg)
NO (1) NO179611C (bg)
OA (1) OA10029A (bg)
PL (1) PL165868B1 (bg)
RO (1) RO109649B1 (bg)
RU (1) RU2111216C1 (bg)
SI (1) SI9110908A (bg)
SK (1) SK279891B6 (bg)
TJ (1) TJ231R3 (bg)
UA (1) UA27226C2 (bg)
WO (1) WO1991014680A1 (bg)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (fr) 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
ITTO20120056A1 (it) * 2012-01-24 2013-07-25 Borla Ind Connettore per linee medicali di infusione, trasfusione e simili
ITTO20130433A1 (it) * 2013-05-29 2014-11-30 Borla Ind Connettore per linee medicali
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695897C3 (de) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DK243084A (da) 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
ES2037385T3 (es) * 1988-01-14 1993-06-16 Akzo N.V. Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
US5120732A (en) * 1988-06-14 1992-06-09 Cassella Aktiengesellschaft Substituted 3-aminosyndone imines, a process for their preparation and their use
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
HRP920561A2 (hr) 1994-04-30
LV10245A (lv) 1994-10-20
MD679G2 (ro) 1997-11-30
WO1991014680A1 (en) 1991-10-03
NO179611B (no) 1996-08-05
SK279891B6 (sk) 1999-05-07
NO914649D0 (no) 1991-11-27
LTIP386A (en) 1994-12-27
CN1051080C (zh) 2000-04-05
FI915569A0 (fi) 1991-11-26
HU901868D0 (en) 1990-08-28
SI9110908A (sl) 1998-06-30
HRP920561B1 (en) 1999-12-31
KR920701182A (ko) 1992-08-11
EP0477315A1 (en) 1992-04-01
CA2054188A1 (en) 1991-09-29
BR9105136A (pt) 1992-08-04
BG95531A (bg) 1993-12-24
NO914649L (no) 1991-11-27
ES2090320T3 (es) 1996-10-16
RO109649B1 (ro) 1995-04-28
OA10029A (en) 1996-10-14
CS85191A3 (en) 1991-11-12
ATE138656T1 (de) 1996-06-15
GR3020684T3 (en) 1996-10-31
JPH04506362A (ja) 1992-11-05
AU638824B2 (en) 1993-07-08
DE69119853D1 (de) 1996-07-04
MC2185A1 (fr) 1992-09-16
DE69119853T2 (de) 1996-10-10
US5403840A (en) 1995-04-04
RU2111216C1 (ru) 1998-05-20
PL165868B1 (pl) 1995-02-28
PL293022A1 (en) 1992-12-28
FI102460B (fi) 1998-12-15
NO179611C (no) 1996-11-13
IL97714A0 (en) 1992-06-21
LT3394B (en) 1995-09-25
CA2054188C (en) 1996-07-23
TJ231R3 (en) 1999-11-24
HUT58109A (en) 1992-01-28
LV10245B (en) 1995-08-20
DK0477315T3 (da) 1996-09-30
CZ287353B6 (cs) 2000-11-15
CN1056688A (zh) 1991-12-04
HU210921B (en) 1995-09-28
AU7574591A (en) 1991-10-21
BG61689B1 (bg) 1998-03-31
FI102460B1 (fi) 1998-12-15
UA27226C2 (uk) 2000-08-15
EP0477315B1 (en) 1996-05-29
MD679F1 (en) 1997-02-28
KR950004705B1 (ko) 1995-05-04
JP2582497B2 (ja) 1997-02-19
GEP19991832B (en) 1999-11-05

Similar Documents

Publication Publication Date Title
US4869904A (en) Sustained release drug preparation
KR101275372B1 (ko) 에스트로겐-시클로덱스트린 복합체의 조성물
US5244881A (en) Compositions based on imipyramine
JPS62103077A (ja) シクロデキストリンにより形成された７−イソプロポキシ−イソフラボンの包接複合体、その製造方法および活性成分として該化合物を含有する医薬組成物
US5403840A (en) Inclusion complexes of N-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same
JP3434828B2 (ja) Ｓｉｎ−１ａシクロデキストリン包接複合体
EP0478732B1 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
HUT72055A (en) Ciklodextrin-vinpocetin complexes process for producing them and pharmaceutical compositions containing them
JPH01287094A (ja) ダナゾール−シクロデキストリン包接化合物
HU211906A9 (en) Inclusion complexes of n-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same
WO2004019989A1 (fr) Compose d'inclusion a base de nateglinide

Legal Events

Date Code Title Description
HP Change in proprietorship
EXP Patent expired